DEF 14ACCCCCIK 0001662579
C4 Therapeutics, Inc.
Proxy statement (DEF 14A) filed .
Definitive proxy statement disclosing matters to be voted on by shareholders, including executive compensation.
Filing facts
- Accession number
- 0001628280-26-028104
- Filer
- C4 Therapeutics, Inc.
- Ticker
- CCCC
- CIK
- 0001662579
- Form type
- DEF 14A
- Form description
- Proxy statement
- Filed at
- April 29, 2026
- SIC code
- 2836
- Last verified
- April 29, 2026SecFilingDex pulls from EDGAR with daily cadence
Provenance
Authoritative source — SEC EDGAR
https://www.sec.gov/Archives/edgar/data/1662579/000162828026028104/0001628280-26-028104-index.htm ↗Filer's full EDGAR submission history
EDGAR · C4 Therapeutics, Inc. (0001662579) ↗Machine-readable JSON twin (LLM-citation friendly)
/api/filing/0001628280-26-028104.jsonSecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.